Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2017 05/19/2017 05/22/2017 05/23/2017 05/24/2017 Date
175.89(c) 177.01(c) 174.92(c) 174.72(c) 174.6229 Last
936 953 1 061 794 1 176 727 1 001 444 671 508 Volume
+0.19% +0.64% -1.18% -0.11% -0.06% Change
More quotes
Financials ($)
Sales 2017 2 657 M
EBIT 2017 666 M
Net income 2017 663 M
Finance 2017 865 M
Yield 2017 -
Sales 2018 3 017 M
EBIT 2018 840 M
Net income 2018 592 M
Finance 2018 1 266 M
Yield 2018 -
P/E ratio 2017 34,74
P/E ratio 2018 43,75
EV / Sales2017 9,29x
EV / Sales2018 8,05x
Capitalization 25 562 M
More Financials
Company
Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function.The company provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing... 
More about the company
Surperformance© ratings of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA, INC.
01:30p ILLUMINA : Sources Sought Notice - 65-- Illumina
05/22 ILLUMINA : Special Notice - Repair and Maintenance for MiSeq and HiSeq 2500 Sequ..
05/22 ILLUMINA : Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Gen..
05/05 ILLUMINA : Management's Discussion and Analysis of Financial Condition and Resul..
05/04 ILLUMINA : to Webcast Live Presentation at the Bank of America Merrill Lynch Hea..
05/04 ILLUMINA : Special Notice - Illumina MiSeq equipment maintenance service
04/27 ILLUMINA : Patent Issued for Methods for Selecting and Amplifying Polynucleotide..
04/25 ILLUMINA : meets 1Q profit forecasts
04/25 ILLUMINA, INC. (NASDAQ : ILMN) Files An 8-K Results of Operations and Financial ..
04/25 ILLUMINA INC : Results of Operations and Financial Condition, Financial Statemen..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/17 PHILIPS CEO : uptake of connected care products progressing slowly
05/15DJMARKET SNAPSHOT : Stock Market Sets Fresh Records As Oil Rallies
05/15 Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on ILLUMINA, INC. 
2015We anticipate a reversal
2013End of the technical recovery
More Strategies
Latest Tweets
03:31pIllumina, Inc. $ILMN Upgraded to Strong-Buy at Vetr Inc.  
05/23When Is Invitae Diagnosed As Oversold? $BMY $DGX $ILMN $JNJ $MYGN $OCX $NVTA .. 
05/23When Is Invitae Diagnosed As Oversold?  
05/23Good guess. $INCY second best biotech performer in S&P (if you don't coun..
1
05/23Illumina upgraded by Vetr Inc. to strong-buy. $197.84 PT.
1
More tweets
Qtime:63
News from SeekingAlpha
05/23 When Is Invitae Diagnosed As Oversold?
05/23 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2017 Update
05/19 Illumina, Inc. 2017 Q1 - Results - Earnings Call Slides
05/01 PROJECT $1M : Q1 2017 Update
04/26 Illumina (ILMN) Q1 2017 Results - Earnings Call Transcript
Advertisement
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 178 $
Spread / Average Target 1,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Norman Fjeldheim Chief Information Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.36.61%25 591
THERMO FISHER SCIENTIF..21.78%67 329
DANAHER CORPORATION7.85%57 550
BOSTON SCIENTIFIC CORP..23.30%36 700
PHILIPS9.45%33 178
INTUITIVE SURGICAL, IN..41.45%32 863
More Results